IMCAS website has a fresh new look! Explore our redesigned website. We're here to help you navigate the new features and welcome your feedback at contact@imcas.com.
English
Español
Français
Português
Русский
简体中文
BREXOGEN INC
韩国
展位号: S363
行业类别
公司简介
At Brexogen, we are developing biomacromolecule cargo-controlled exosome as a cell-free regenerative medicine. By using induced pluripotent stem cells derived mesenchymal stem cells and stem cell stimulation technologies, we control the biomacromolecule cargo potential and composition inside exosome.